Mikota Ltd

Overview

Legal name

MIKOTA LTD

Region

London

Registered address

FLAT 43

3 PURBECK GARDENS

LONDON

ENGLAND

SE26 5FF

Insolvency history

No

Latest accounts

Financial period: 1 Jun 2023 to 31 May 2024

FILLETEDACCOUNTS

Turnover

Unknown

Profit / Loss

Unknown

Employees

1

Company events

Reference milestones and recent Companies House filing stream events.

6 events

28 Feb

2027

Accounts due

Accounts Due

Next accounts due date

15 Jun

2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

01 Jun

2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 May

2025

Accounts filed

Accounts

Last accounts made up date

22 Nov

2024

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQ0NDU2NTM0MGFkaXF6a2N4

Published 22 Nov 2024 09:17

01 Aug

2014

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards

First funded

2017

Funded years

2017, 2018, 2020

Age at first award

2 years

Projects

2020 Collaborative R&D Lead participant

Novel hemocyanin protein adjuvant for animal vaccine market.

1 Nov 2020 to 31 Jul 2021

Awarded

£94,384

Total cost £94,384

Mikota Ltd in collaboration with Cardiff University and Royal Veterinary College (University of London) are evaluating a new protein adjuvant as a vaccine delivery platform, primarily aimed at the companion and livestock market. This project is building on Mikota's earlier hemocyanin work in creating novel constructs to address research demonstrating that...

2018 Feasibility Studies Lead participant

Extraction and purification of a novel hemocyanin through implementation of new technologies.

1 Aug 2018 to 30 Sep 2019

Awarded

£80,852

Total cost £115,505

"Mikota Ltd is looking to build on early investigative work into hemocyanin from the blood of the slipper limpet, an invasive, non-native species to UK shores. Having successfully identified hemocyanin proteins in the limpets as well as drafted and tested a basic extraction protocol, Mikota now aims to scale up production of this hemocyanin to a commercia...

2017 Feasibility Studies Lead participant

Feasibility study on a non-mammalian marine collagen which has similar properties to mammalian collagen.

1 Jun 2017 to 28 Feb 2018

Awarded

£64,278

Total cost £91,825

Mikota Ltd is a startup in the high value niche market of novel biomaterials from the marine environment. This project is for a feasibility study into a new and novel non-mammalian marine collagen which is thermally stable in its native form, in line with bovine collagen, the gold standard for biomaterials. This will be a product that, from early indicati...

Product types

Collaborative R&D Feasibility Studies